CryoBalloon Ablation for Treatment of Duodenal Adenomas
NCT03847636 is an interventional trial sponsored by Johns Hopkins University. As of 21 Nov 2026, it is completed. It studies Duodenal Adenomas and Familial Adenomatous Polyposis. The registry lists an enrollment of 33 participants at 4 sites in 1 country. The registry lists a start date of 13 May 2019 and a primary completion date of 1 Jun 2025.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03847636 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Johns Hopkins University |
| Enrollment | 33 |
| Registered sites | 4 |
| Countries | 1 |
| Conditions | Duodenal Adenomas and Familial Adenomatous Polyposis |
| Start | 13 May 2019 |
| Primary completion | 1 Jun 2025 |
| Study completion | 1 Jun 2026 |
| Last update posted | 5 Aug 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Marcia I. Canto, MD
Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Johns Hopkins Hospital
Baltimore
- Northwell Health
Manhasset
- Geisinger Medical Center
Danville
- Methodist Dallas Medical Center
Dallas
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT03847636
Each answer restates registry values shown on this page.
What is NCT03847636?
NCT03847636 is an interventional trial sponsored by Johns Hopkins University. It studies Duodenal Adenomas and Familial Adenomatous Polyposis.
Who leads NCT03847636?
The registry names Marcia I. Canto, MD (principal investigator, Johns Hopkins University) as the overall official.
Where does NCT03847636 run?
The registry lists 4 sites in 1 country. Every site with a stated country is in one country: United States.
When did NCT03847636 end?
The registry lists a primary completion date of 1 Jun 2025 and a study completion date of 1 Jun 2026. The sponsor last updated the record on 5 Aug 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.